Free CME from PeerView


Endocrinology & Diabetes CME

Credits: 1.0 CME
Medical Learning Institute, Inc.
A Renewed Look at MRA Therapy: Improving Renal Outcomes and Reducing Risks in Patients With Type 2 Diabetes
Rajiv Agarwal, MD, MS
May 13, 2022
Credits: 1.0 CME / NCPD / CE
PVI, PeerView Institute for Medical Education
Building Skills for Clinical Practice: Optimizing Insulin Management and Personalizing Diabetes Care With Faster-Acting Formulations and Newer Options in Delivery Technology
Lucia M. Novak, MSN, ANP-BC, BC-ADM
April 27, 2022
Credits: 1.0 CME
Medical Learning Institute, Inc.
Is Synergism the Secret to Success? Candid Conversations on Targeting GIP and GLP-1 to Individualize Treatment in Patients With T2DM and Obesity
Javier Morales, MD, FACP, FACE
April 08, 2022
Credits: 0.5 CME
Medical Learning Institute, Inc.
Complementary Actions All Around: Lowering Cardiometabolic Risks While Achieving Glycemic Targets With GLP-1 RAs
John B. Buse, MD, PhD
March 25, 2022
Credits: 0.5 CME
PVI, PeerView Institute for Medical Education
Putting the Pieces Together: Would You Recognize Acute Hepatic Porphyria If You Saw It?
Herbert L. Bonkovsky, MD
February 25, 2022
Rohit Loomba, MD, MHSc
Credits: 0.5 CME
AGA Institute
Test Your Knowledge of What’s Now and What’s Next: Modification of Metabolic Risk Factors to Improve Liver-Related and Cardiovascular‐Related Outcomes in NASH
Rohit Loomba, MD, MHSc
February 11, 2022
Bradley S. Miller, MD, PhD
Credits: 0.5 CME
PVI, PeerView Institute for Medical Education
Advances in Pediatric Growth Hormone Therapy: Visualizing the Impact on Individualized Care
Bradley S. Miller, MD, PhD
December 30, 2021
Credits: 1.5 CME / MOC
Penn State College of Medicine
Clinical Colloquia in Retinal Disease: Updating Evidence-Based, Patient-Centered Care for Diabetic Retinopathy
Carl Regillo, MD
November 22, 2021
Domenica M. Rubino, MD, Donna H. Ryan, MD, FTOS
Credits: 1.0 CME
Medical Learning Institute, Inc.
Gut Feeling: The Increasing Importance of GLP-1–Based Therapies for Personalized Obesity Management
Domenica M. Rubino, MD /
November 09, 2021
Credits: 1.00 CME
Medical Learning Institute, Inc.
The Contemporary Use of GLP-1 RAs to Individualize Therapy in T2DM: Candid Conversations on Glycemic and Nonglycemic Effects
James R. Gavin III, MD, PhD
July 27, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Determining Which Patients Will Benefit From GLP-1 RAs: Applying Guidelines and Evidence to Individualize Treatment Decisions in T2DM
Vanita R. Aroda, MD
July 16, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Demystifying the Role of Incretin-Based Weight-Loss Pharmacotherapy: A Patient-Centered Approach to Overcoming Barriers and Addressing Underlying Causes of Obesity
Donna H. Ryan, MD, FTOS
July 15, 2021
Christopher D. Still, DO, FACP, FTOS / Alan C. Wittgrove, MD, FASMBS, FACS
Credits: 1.00 CME
Medical Learning Institute, Inc.
Going With Your Gut: Targeting Long-Term Weight Loss With Current and Emerging Incretin-Based Pharmacotherapy
Christopher D. Still, DO, FACP, FTOS / Alan C. Wittgrove, MD, FASMBS, FACS
July 07, 2021
Credits: 1.00 CME
Penn State College of Medicine
Management of Hyperlipidemia in the Family Medicine Setting: Diagnosis, Management, and the Role of Emerging Lipid-Lowering Therapies
James A. Underberg, MD, MS, FACPM, FACP, FNYAM, FASPC, FNLA
June 22, 2021
Credits: 1.50 CME
Medical Learning Institute, Inc.
Recognizing and Treating Hyperkalemia in Patients With Heart Failure and/or Chronic Kidney Disease: An Update for Hospitalists
George L. Bakris, MD
May 31, 2021
Credits: 1.50 CME / MOC
University of Florida College of Medicine
Lower Is Better: Novel Therapeutic Strategies Targeting PCSK9 for Reducing LDL-C Levels in Patients With Hyperlipidemia and ASCVD
Professor Kausik Ray
May 27, 2021
Medical Learning Institute, Inc.
The Evolving Role of Oxybate Agents in the Management of Narcolepsy: A Visual Exploration of Individualized Care
Richard K. Bogan, MD, FCCP, FAASM
May 18, 2021
Medical Learning Institute, Inc.
Acute Hepatic Porphyria: Disease Diagnosis and Revelations Regarding the Role of siRNA Therapy
Karl E. Anderson, MD
April 15, 2021
Medical Learning Institute, Inc.
Simulation – Partnering With Peers and Patients: Achieving T2DM Treatment Goals With GLP-1 RA Therapy
Jay H. Shubrook, DO, FAAFP, FACOFP
March 31, 2021
Medical Learning Institute, Inc.
A Visual Exploration of New Opportunities in Thyroid Cancer: Targeting RET Alterations to Optimize Outcomes
Marcia S. Brose, MD, PhD
December 30, 2020
Joslin Diabetes Center
Highlighting the Vital Role of Primary Care in Identifying and Optimizing the Treatment of Diabetic Retinopathy and Diabetic Macular Edema
Andrew Moshfeghi, MD / MBA
November 18, 2020
Penn State College of Medicine
Show Me the Data: Improving Renal Outcomes With Glucose-Lowering Therapy in the Individualized Management of T2DM
George L. Bakris, MD
November 02, 2020
PeerView Institute
The Art of Medicine: Creating Treatment Regimens With GLP-1 RAs to Reduce Cardiovascular Risks in Patients With T2DM
Lucia M. Novak, MSN, ANP-BC, BC-ADM, CDTC
October 28, 2020
Medical Learning Institute, Inc.
Leveraging the Tools at Hand: Current Perspectives on Weight-Loss Pharmacotherapy for Obesity Management
Ken Fujioka, MD
September 23, 2020
Penn State College of Medicine
Complex Cases in Contemporary Practice: Applying New Evidence for SGLT2 Inhibitors in the Management of Patients With Comorbid Cardiometabolic Diseases
John B. Buse, MD, PhD
July 24, 2020
Medical Learning Institute, Inc.
Test Your Knowledge: Current Guidance on GLP-1 Receptor Agonists to Individualize Treatment for T2DM
Vanita R. Aroda, MD
June 25, 2020

Upcoming Live Events

Education Collections

Recent CME Podcast

More Podcasts from PeerView